Mesoblast MESO
NASDAQ MESO
$12.83 +0.42 (+3.38%)
At close: Oct 21, 2026 · 4:00 PM EDT

Mesoblast (MESO) Non-Current Debt (2018 - 2026)

Updated

Mesoblast's Non-Current Debt was $61.16 million in the quarter ended Sep 30, 2018, up 3.0% from the prior quarter.

Analysis

Mesoblast (MESO) Non-Current Debt (2018 - 2026) Analysis & Trends

As of Jun 30, 2018, Non-Current Debt at Mesoblast came in at $59.4 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 Mesoblast 1.66 Bn 1.23 Bn - 108.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.64 Mn
Dec 31, 2025 60.13 Mn
Jun 30, 2025 67.74 Mn
Dec 31, 2024 101.48 Mn
Jun 30, 2024 100.48 Mn
Dec 31, 2023 107.23 Mn
Jun 30, 2023 102.81 Mn
Mar 31, 2023 99.04 Mn
Dec 31, 2022 96.98 Mn
Sep 30, 2022 94.19 Mn
Jun 30, 2022 91.62 Mn
Mar 31, 2022 88.65 Mn
Dec 31, 2021 86.54 Mn
Sep 30, 2021 42.65 Mn
Jun 30, 2021 41.05 Mn
Mar 31, 2021 39.85 Mn
Dec 31, 2020 49.09 Mn
Sep 30, 2020 56.10 Mn
Jun 30, 2020 57.02 Mn
Mar 31, 2020 59.95 Mn
API Access

Mesoblast Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=MESO&period=max&api_key=YOUR_API_KEY